Andrew Peach

Our correspondent Samira Hussain, who's in Kiev.

And for a more in-depth look at what's happening in Ukraine, you can go to YouTube, search for BBC News, click on the logo, then choose podcasts and the Global News podcast.

There's a new story available there every weekday.

As Christians prepare to celebrate the birth of Jesus Christ in Bethlehem, today the West Bank city is considered to be under Israeli occupation by many.

Women giving birth there now often turn to the Holy Family Hospital run by the Catholic Order of Malta.

Our reporter Fahima Abdul-Rahman has been following one mother's journey.

That report from Fahima Abdul-Rahman.

Regulators in the United States have approved a pill version of the weight loss drug Wegovi.

It's the first time the US Food and Drug Administration has given the go-ahead for daily oral medication to treat obesity.

Here's Stephanie Tillotson.

The injectable at the moment for Wegovy is 2.4 milligrams.

So that's how much you take once weekly.

What the dose that they're reporting it to be effective and have been approved for is 25 milligrams, so 10 times that per day.

So you have to take 70 times more, shall we say, to get past the stomach.

As a result, it will be significantly more expensive

We have been looking for effective anti-obesity management pills for 50 years and we've historically had lots of failure.

Now this is the first peptide pill to come out which would be easy to use.

which is going to produce weight loss of between 15% to 17%, according to the clinical trials.

Now, that's a significant degree of weight loss compared with what we've seen previously.

It's not quite at the levels of bariatric surgery, but it's getting there.